Premiere Date: January 20, 2015
Expiration Date: January 20, 2016 [Expired]
This activity offers CE credits for:
1. Physicians (CME)
To understand some psychodynamic perspectives of psychosis and how this relates to therapeutic approaches.
At the end of this CE activity, participants should be able to:
1. Understand the unconscious mental activity that may take place during a psychotic episode
2. Define how these episodes affect not only the patient but others as well
3. Make treatment decisions based on the psychodynamic perspectives
This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for 1.5 AMA PRA Category 1 Credit™.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.
The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Brian V. Martindale, FRCP, FRCPsych, has no disclosures to report.
Benjamin Brent, MD, MS (peer/content reviewer), has no disclosures to report.
Applicable Psychiatric Times staff and CME Outfitters staff have no disclosures to report.
UNLABELED USE DISCLOSURE
Faculty of this CME/CE activity may include discussion of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
Dr Martindale is Chair of the International Society for the Psychological and Social Approaches to Psychosis (www.isps.org). From 2005 to 2012, he was a consultant psychiatrist on an early intervention in psychosis team in the northeast of the UK. He is also a psychoanalyst and a fellow of both the Royal College of Psychiatrists and the Royal College of Physicians. He is Honorary President of the European Federation for Psychoanalytic Psychotherapy in the Public Sector (www.efpp.org).
1. Littell J. The Kindly Ones. London: Chatto and Windus; 2009.
2. Freud S. Neurosis and psychosis. In: Strachcy J, trans-ed. The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol 19. London: Hogarth Press; 1961:151.
3. Sinason M. Who is the mad voice inside? Psychoanal Psychother. 1993;7:207-221.
4. Eliot TS. Burnt Norton. London: Faber & Faber; 1935.
5. Hinshelwood RD. Suffering Insanity. Psychoanalytic Essays on Psychosis. New York: Brunner-Routledge; 2004.
6. Brent BK, Fonagy P. A mentalisation based approach to disturbances of social understanding in schizophrenia. In: Lysaker P, Dimaggio G, Brüne M, eds. Social Cognition and Metacognition in Schizophrenia: Psychopathology and Treatment Approaches. New York: Elsevier Press; 2014.
7. Tienari P, Wynne LC, Sorri A, et al. Genotype-environment interaction in schizophrenia-spectrum disorder: long-term follow-up study of Finnish adoptees. Br J Psychiatry. 2004;184:216-222.
8. Read J, Bentall RP. Negative childhood experiences and mental health: theoretical, clinical and primary prevention implications [published correction appears in Br J Psychiatry. 2012;201:328]. Br J Psychiatry. 2012;200:89-91.
9. Gumley A. The developmental roots of compromised mentalization in complex mental health disturbances of adulthood: an attachment-based conceptualization. In: Dimaggio G, Lysaker PH, eds. Metacognition and Severe Adult Mental Disorders: From Research to Treatment. New York: Routledge; 2010:45-63.
10. Lysaker PH, Buck KD. Metacognitive capacity as a focus of individual psychotherapy in schizophrenia. In: Dimaggio G, Lysaker PH, eds. Metacognition and Severe Adult Mental Disorders: From Research to Treatment. New York: Routledge; 2010:217-232.
11. Bebbington P, Kuipers L. The predictive utility of expressed emotion in schizophrenia: an aggregate analysis [published correction appears in Psychol Med. 1995;25:215]. Psychol Med. 1994;24:707-718.
12. Alanen YO. Schizophrenia: Its Origins and Need-Adapted Treatment. London: Karnac Books; 1997.
13. Fuller P. Surviving, Existing or Living. Phase-Specific Therapy for Severe Psychosis. New York: Routledge; 2013.
14. Gottdiener W, Haslam N. The benefits of individual psychotherapy in people diagnosed with schizophrenia. Ethic Human Sci Serv. 2002;4:163-187.
15. Gunderson JG, Frank AF, Katz HM, et al. Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophr Bull. 1984;10:564-598.
16. Rosenbaum B, Harder S, Knudsen P, et al. Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome. Psychiatry. 2012;75:331-341.
17. Rosenbaum B, Martindale B, Summers A. Supportive psychodynamic psychotherapy for psychosis. Adv Psychiatr Treat. 2013;19:310-318.
18. National Institute for Health and Care Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary. http://www.nice.org.uk/guidance/cg82. Accessed December 5, 2014.
19. Seikkula J, Aaltonen J, Alakare B, et al. Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: treatment principles, follow-up outcomes, and two case studies. Psychother Res. 2006;16:214-228.
20. Seikkula J, Alakare B, Aaltonen J. The Comprehensive Open-Dialogue Approach in Western Lapland: II. Long-term stability of acute psychosis outcomes in advanced community care. Psychosis. 2011;3:192-204.
21. The New York City Department of Health and Mental Hygiene. Parachute NYC: A Model of Care for People in Emotional Crisis. http://www.nyc.gov/html/doh/html/mental/parachute.shtml. Accessed December 5, 2014.